Taekyung Chemical Co., Ltd. (KRX:006890)
South Korea · Delayed Price · Currency is KRW 7,560.00
+170.00 (2.30%)
Feb 5, 2026, 3:30 PM KST
Taekyung Chemical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 62,951 | 71,116 | 70,748 | 59,613 | 54,066 | 47,061 |
Other Revenue | -0 | -0 | -0 | -0 | - | - |
| 62,951 | 71,116 | 70,748 | 59,613 | 54,066 | 47,061 | |
Revenue Growth (YoY) | -12.52% | 0.52% | 18.68% | 10.26% | 14.89% | 12.50% |
Cost of Revenue | 44,813 | 43,593 | 39,560 | 36,739 | 31,246 | 29,513 |
Gross Profit | 18,138 | 27,524 | 31,188 | 22,875 | 22,820 | 17,548 |
Selling, General & Admin | 12,318 | 12,826 | 12,460 | 11,491 | 9,676 | 8,752 |
Amortization of Goodwill & Intangibles | 8.27 | 8.01 | 9.43 | 8.96 | 7.31 | 1.39 |
Other Operating Expenses | 141.09 | 195.28 | 125.9 | 159.73 | 117.07 | 78.72 |
Operating Expenses | 13,247 | 13,818 | 13,311 | 12,474 | 10,685 | 9,846 |
Operating Income | 4,892 | 13,706 | 17,877 | 10,401 | 12,135 | 7,702 |
Interest Expense | -611.77 | -18.49 | -9.52 | -8.22 | -12.45 | -11.2 |
Interest & Investment Income | 2,194 | 2,758 | 3,269 | 2,370 | 1,911 | 670.1 |
Earnings From Equity Investments | -192.77 | -192.77 | - | - | - | 2.62 |
Currency Exchange Gain (Loss) | 13.65 | 81.47 | -11.81 | -7.27 | -8.39 | 1,438 |
Other Non Operating Income (Expenses) | 40.05 | 44.53 | 120.38 | 50.5 | 127.1 | 133.61 |
EBT Excluding Unusual Items | 6,335 | 16,379 | 21,246 | 12,806 | 14,152 | 9,935 |
Gain (Loss) on Sale of Investments | 1,890 | -585.88 | 1,188 | -808.49 | -189.01 | - |
Gain (Loss) on Sale of Assets | -1.48 | 1.39 | -9.76 | 40.95 | 18.12 | 36.57 |
Asset Writedown | -718.99 | -716.28 | -770.77 | - | - | - |
Pretax Income | 7,504 | 15,078 | 21,654 | 12,038 | 13,981 | 9,972 |
Income Tax Expense | 573.36 | 2,447 | 4,282 | 3,306 | 3,066 | 2,237 |
Earnings From Continuing Operations | 6,931 | 12,631 | 17,372 | 8,732 | 10,915 | 7,734 |
Minority Interest in Earnings | 0.42 | -15.04 | 47.29 | 135.12 | - | - |
Net Income | 6,931 | 12,616 | 17,419 | 8,868 | 10,915 | 7,734 |
Net Income to Common | 6,931 | 12,616 | 17,419 | 8,868 | 10,915 | 7,734 |
Net Income Growth | -49.94% | -27.58% | 96.44% | -18.75% | 41.12% | -21.26% |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | 11 |
Shares Change (YoY) | -0.04% | - | - | - | -0.19% | -0.84% |
EPS (Basic) | 611.70 | 1113.10 | 1536.93 | 782.40 | 963.01 | 681.10 |
EPS (Diluted) | 611.70 | 1113.10 | 1536.93 | 782.40 | 963.01 | 681.10 |
EPS Growth | -49.91% | -27.58% | 96.44% | -18.75% | 41.39% | -20.59% |
Free Cash Flow | -15,241 | -7,566 | 3,475 | 4,237 | 8,754 | 5,144 |
Free Cash Flow Per Share | -1345.02 | -667.51 | 306.59 | 373.82 | 772.39 | 453.00 |
Dividend Per Share | 180.000 | 180.000 | - | - | - | - |
Gross Margin | 28.81% | 38.70% | 44.08% | 38.37% | 42.21% | 37.29% |
Operating Margin | 7.77% | 19.27% | 25.27% | 17.45% | 22.45% | 16.37% |
Profit Margin | 11.01% | 17.74% | 24.62% | 14.88% | 20.19% | 16.43% |
Free Cash Flow Margin | -24.21% | -10.64% | 4.91% | 7.11% | 16.19% | 10.93% |
EBITDA | 7,372 | 16,184 | 20,216 | 12,763 | 14,383 | 9,985 |
EBITDA Margin | 11.71% | 22.76% | 28.57% | 21.41% | 26.60% | 21.22% |
D&A For EBITDA | 2,481 | 2,478 | 2,339 | 2,362 | 2,248 | 2,283 |
EBIT | 4,892 | 13,706 | 17,877 | 10,401 | 12,135 | 7,702 |
EBIT Margin | 7.77% | 19.27% | 25.27% | 17.45% | 22.45% | 16.37% |
Effective Tax Rate | 7.64% | 16.23% | 19.77% | 27.46% | 21.93% | 22.44% |
Advertising Expenses | - | 56.66 | 112.07 | 244.39 | 16.5 | 13.23 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.